FTC and seven states seek contempt ruling against Shkreli over pharma ban
Published The Federal Trade Commission and seven states asked a federal court on 13 October 2026 to hold Martin Shkreli in contempt for allegedly trading stocks in at least 60 pharmaceutical companies in violation of his lifetime industry ban.
3 sources